Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
J&J Targets Double-Digit Growth by 2030 Despite Stelara Drag
10:46am, Thursday, 16'th Apr 2026
J&J targets double-digit growth by 2030 despite Stelara hit, banking on Innovative Medicine strength, MedTech gains and new launches.
Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson
10:16am, Thursday, 16'th Apr 2026
XLRP is a severe, progressive genetic eye disease causing early-onset night blindness and peripheral vision loss, leading to legal blindness by age 40–45.
The top 3 best performing dividend stocks of 2026
07:34am, Thursday, 16'th Apr 2026
There has been a notable break with tradition in 2026 as major dividend stocks – generally purchased for regular income and not growth – have been recording exceptionally strong equity market perf
Johnson & Johnson Q1 Earnings Call Highlights
01:03am, Thursday, 16'th Apr 2026
Johnson and Johnson (NYSE: JNJ) reported first-quarter 2026 results that executives said put the company "off to a fast start" in what management has described as a year of accelerated growth. On the
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
04:11pm, Wednesday, 15'th Apr 2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Bank of America 2026 Healthcare Conference on Tuesday, May 12th, 2026. Management will participate in a Fireside
These Analysts Boost Their Forecasts On Johnson & Johnson Following Strong Q1 Results
01:43pm, Wednesday, 15'th Apr 2026
Johnson & Johnson (NYSE: JNJ) on Tuesday posted upbeat earnings for the first quarter.
Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?
12:46pm, Wednesday, 15'th Apr 2026
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Johnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish Analyst
12:37pm, Wednesday, 15'th Apr 2026
• Johnson & Johnson stock is trending lower. Why is JNJ stock trading lower?
3 High Yield Dividend Paying Stocks Perfect For Passive Income
09:25am, Wednesday, 15'th Apr 2026
Market volatility, tariff uncertainty, and rising living costs remind investors that earned income alone is fragile.
Silverbullet Data Services shares lifted as it flags 'better than expected' financials
06:07am, Wednesday, 15'th Apr 2026
Silverbullet Data Services Group PLC (LSE:SBDS) saw its shares rise 10.5%, to 21p, after revealing its first period of positive EBITDA, in the first quarter...
Johnson & Johnson $JNJ Shares Bought by Carnegie Investment Counsel
04:34am, Wednesday, 15'th Apr 2026
Carnegie Investment Counsel boosted its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 13.9% during the fourth quarter, according to the company in its most recent filing with the Securities
Johnson & Johnson (JNJ) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amidst Competitive Challenges
02:00am, Wednesday, 15'th Apr 2026
Worldwide Sales: $24.1 billion, increased 6.4% operationally.Net Earnings: $5.2 billion, with diluted earnings per share of $2.14.Adjusted Net Earnings: $6.6 b
Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript
05:01pm, Tuesday, 14'th Apr 2026
Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript
What Johnson & Johnson Earnings Signal for Healthcare ETFs
04:51pm, Tuesday, 14'th Apr 2026
With Q1 earnings season well underway, it was Johnson & Johnson (JNJ) giving investors a peek at how the broader healthcare sector might perform. The healthcare giant beat expectations on Tuesday in r
What Makes a Healthcare Stock Worth Holding Through a Recession?
04:39pm, Tuesday, 14'th Apr 2026
Healthcare may be considered a defensive sector, but not all healthcare stocks make for strong defensive plays. For one, consider it best to focus on healthcare companies with deep economic moats.
